SREBF2 and colonic neoplasm: Here we show that inhibition of lipid biosynthesis by knocking down SREBP1 or SREBP2 significantly inhibits cell proliferation in vitro and tumorigenesis in vivo as a result of decreased fatty acid and cholesterol levels in colon cancer cells.